Radiopharm Theranostics Limited (ASX:RAD)
Australia
· Delayed Price · Currency is AUD 0.0200
0.00 (0.00%)
Apr 29, 2026, 3:47 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 70.88 million as of April 28, 2026. Its market cap has increased by 44.62% in one year.
Market Cap
70.88M
Enterprise Value
34.53M
Revenue
16.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 70.88M, a decrease of -30.05%. That is a compound annual growth rate of -7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 70.88M | -20.00% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 78.16M |
| Cynata Therapeutics | 80.73M |
| Amplia Therapeutics | 84.66M |
| Paradigm Biopharmaceuticals | 85.84M |
| Botanix Pharmaceuticals | 87.05M |
| Neurizon Therapeutics | 62.34M |
| Arovella Therapeutics | 92.47M |
| Prescient Therapeutics | 57.31M |